1Major outcomes in hish-risk hypertensive patients randomized to ansiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The antihypetensive and lipid-lowering treatment to prevent heart attack trial(ALLHAT). JAMA,2002,288:2981-2997. 被引量：1
2Yusuf S, Sleight P, Pogue J, et al. Effect of an angiotensinconverting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study investigators. N Engl J Med,2000,342:145-153. 被引量：1
3Daldof B, Devereux B.B, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study ( LIFE ): a randomised Uial against atenolol. Lancet,2002,359:995-1003. 被引量：1
4Williams B. Drug treatment of hypertension. BMJ,2003,326:61-62. 被引量：1
3Hollenberg NK, Mickiewicz CW. Postmarketing surveillance in 70898 patients treated with a triamterene hydrochlorothiazide combination. Am J Cardiol, 1989,63:37B-41B. 被引量：1
4Maroko PR, Mcdevitt JT, Fox MJ, et al. Antihypertensive effectiveness of very low doses of hydrochlorothiazide result of the PHICOG trial. Clin Ther, 1989,11:94-119. 被引量：1
5Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper in essential hypertention. Circulation, 1999,100:1635-1638. 被引量：1
6Marvin M. Current recomendations for the treatment of hypertention: Are they still valid? J Hypenens, 2002,20(Suppl 1):S3 -S 10. 被引量：1
7Curb JD, Presser SL, Cutler JA, et al. Effect of dioretic-based antihyper-tensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA, 1996,276:1886-1892. 被引量：1
8Gress TW, Nieto FJ, Shahar E, et al. Hypertension and antihypertensive therapy a tisk factors for type2 diabetes mellitus. Neng J Med, 2000,342:905-912. 被引量：1
9Fubrg CD, Pasty b, cutter JA. Blood pressure and cardiovascular disease. In: yusuf S, eds. Evidence Based Cardiology. London: BMJ Books, 1998,235. 被引量：1
10Ramsey SD, Neil N, Sullivan SD, et al. An economic evaluation of the JNC hypertension guidelines using data from randomized trial. Am Board Fam Prac, 1999,12:105-114. 被引量：1
